Cases

Case 02: Uterocervical cancer

Case 02: Uterocervical cancer

Treatment Performed

“Combined immunotherapy for cancer” was performed for advanced cervical cancer refractory to standard therapies, by combining the cancer vaccine therapy (one course) and a drug to inhibit immunosuppression.

Treatment Outcome

Slight shrinkage of pelvic mass

Before treatment
4 weeks after treatment initiation
7 weeks after treatment initiation

Amelioration of bilateral hydronephrosis

Before treatment
4 weeks after treatment initiation
7 weeks after treatment initiation

The tumor marker decreased

Tumor marker CA19-9